Quest Pharmatech Stock Price Prediction
| QPT Stock | CAD 0.03 0.01 25.00% |
Oversold Vs Overbought
40
Oversold | Overbought |
Quest PharmaTech stock price prediction is an act of determining the future value of Quest PharmaTech shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Quest PharmaTech's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Quest PharmaTech and does not consider all of the tangible or intangible factors available from Quest PharmaTech's fundamental data. We analyze noise-free headlines and recent hype associated with Quest PharmaTech, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Quest PharmaTech based on different types of headlines from major news networks to social media. The Quest stock price prediction module provides an analysis of price elasticity to changes in media outlook on Quest PharmaTech over a specific investment horizon. Using Quest PharmaTech hype-based prediction, you can estimate the value of Quest PharmaTech from the perspective of Quest PharmaTech response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Quest PharmaTech. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Quest PharmaTech to buy its stock at a price that has no basis in reality. In that case, they are not buying Quest because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Quest PharmaTech after-hype prediction price | CAD 0.03 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Quest |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Quest PharmaTech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Quest PharmaTech After-Hype Price Prediction Density Analysis
As far as predicting the price of Quest PharmaTech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Quest PharmaTech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Quest PharmaTech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Quest PharmaTech Estimiated After-Hype Price Volatility
In the context of predicting Quest PharmaTech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Quest PharmaTech's historical news coverage. Quest PharmaTech's after-hype downside and upside margins for the prediction period are 0.00 and 13.73, respectively. We have considered Quest PharmaTech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Quest PharmaTech is out of control at this time. Analysis and calculation of next after-hype price of Quest PharmaTech is based on 3 months time horizon.
Quest PharmaTech Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Quest PharmaTech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Quest PharmaTech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Quest PharmaTech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.13 | 13.70 | 0.00 | 0.00 | 0 Events / Month | 1 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.03 | 0.03 | 0.00 |
|
Quest PharmaTech Hype Timeline
Quest PharmaTech is at this time traded for 0.03on TSX Venture Exchange of Canada. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Quest is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at -0.13%. %. The volatility of related hype on Quest PharmaTech is about 52190.48%, with the expected price after the next announcement by competition of 0.03. About 17.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.08. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Quest PharmaTech recorded a loss per share of 0.12. The entity last dividend was issued on the 21st of July 2005. Assuming the 90 days horizon the next estimated press release will be within a week. Check out Quest PharmaTech Basic Forecasting Models to cross-verify your projections.Quest PharmaTech Related Hype Analysis
Having access to credible news sources related to Quest PharmaTech's direct competition is more important than ever and may enhance your ability to predict Quest PharmaTech's future price movements. Getting to know how Quest PharmaTech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Quest PharmaTech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| COMM | BMO Global Communications | (0.03) | 5 per month | 0.50 | 0.04 | 1.17 | (1.13) | 3.01 | |
| ICE | Canlan Ice Sports | (0.03) | 4 per month | 1.10 | (0.04) | 2.52 | (2.29) | 9.25 | |
| PMZ-UN | Primaris Retail RE | 0.07 | 2 per month | 0.00 | (0.09) | 1.93 | (2.35) | 5.01 | |
| TGS | TGS Esports | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VZ | Verizon Communications CDR | (0.25) | 1 per month | 0.93 | 0.05 | 1.69 | (1.34) | 8.97 | |
| HAM | Highwood Asset Management | 0.03 | 2 per month | 1.70 | 0.16 | 6.25 | (3.41) | 21.32 | |
| HOT-U | American Hotel Income | (0.02) | 3 per month | 0.00 | (0.21) | 3.23 | (8.77) | 21.08 | |
| AWI | Advent Wireless | 0.02 | 2 per month | 0.00 | (0.04) | 0.00 | 0.00 | 14.49 |
Quest PharmaTech Additional Predictive Modules
Most predictive techniques to examine Quest price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Quest using various technical indicators. When you analyze Quest charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Quest PharmaTech Predictive Indicators
The successful prediction of Quest PharmaTech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Quest PharmaTech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Quest PharmaTech based on analysis of Quest PharmaTech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Quest PharmaTech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Quest PharmaTech's related companies. Story Coverage note for Quest PharmaTech
The number of cover stories for Quest PharmaTech depends on current market conditions and Quest PharmaTech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Quest PharmaTech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Quest PharmaTech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Quest PharmaTech Short Properties
Quest PharmaTech's future price predictability will typically decrease when Quest PharmaTech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Quest PharmaTech often depends not only on the future outlook of the potential Quest PharmaTech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Quest PharmaTech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 169.1 M |
Check out Quest PharmaTech Basic Forecasting Models to cross-verify your projections. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Quest Stock analysis
When running Quest PharmaTech's price analysis, check to measure Quest PharmaTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest PharmaTech is operating at the current time. Most of Quest PharmaTech's value examination focuses on studying past and present price action to predict the probability of Quest PharmaTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest PharmaTech's price. Additionally, you may evaluate how the addition of Quest PharmaTech to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |